| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |